5 Results for "

ERα degrader2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "ERα degrader2" in MCE Product Catalog:

Cat. No.: HY-132194
CAS No.: 2235396-63-9
Purity:  99.71%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

ERα degrader-2 is a selective estrogen receptor degrader (SERD) with potent binding affinity with ERα (IC50=17.1 nM), good degradation efficacy (EC50=0.3 nM). ERα degrader-2 exhibits favorable pharmacokinetic properties and excellent agentgability, can be used for HER + breast cancer research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111846
CAS No.: 1351169-29-3
Purity:  98.92%
Research Areas:  

Cancer

PROTAC ERα Degrader-2 is a ERα PROTAC degrader. PROTAC ERα Degrader-2 significantly down-regulates the level of ERα in MCF-7 cells .
loading...
    loading...
Cat. No.: HY-111846R
CAS No.: 1351169-29-3
Research Areas:  

Cancer

PROTAC ERα Degrader-2 (Standard) is the analytical standard of PROTAC ERα Degrader-2 (HY-111846). This product is intended for research and analytical applications. PROTAC ERα Degrader-2 (Compound 11) is a ERα PROTAC degrader. PROTAC ERα Degrader-2 significantly down-regulates the level of ERα in MCF-7 cells.(Pink: AR ligand (HY-43962), Blue: IAP Ligand (HY-177389), Black: Linker (HY-128833)) .
loading...
    loading...
Cat. No.: HY-128528
PROTAC ER Degrader-2 is an intermediate for synthesis of PAC. PAC, consists the ADCs linker and PROTACs, conjugated to an antibody. PAC extracts from patent WO2017201449A1, compound LP2. PAC conjugated to an antibody is a more marked estrogen receptor-alpha (ERα) degrader compared to PROTAC (without Ab) .
loading...
    loading...
Cat. No.: HY-177389
Research Areas:  

Cancer

IAP ligand 5 is a IAP ligand. IAP ligand 5 can be used to synthesize PROTAC ERα Degrader-2 (HY-111846).
loading...
    loading...